Why Peptide Half-Life Matters in Research Settings
When researchers work with peptides, one of the most critical variables to understand is half-life — the time it takes for a peptide's concentration to reduce by 50% in a biological system. This single data point influences dosing frequency, stability protocols, and the overall design of any research model.
Without a reliable reference, even experienced researchers can find themselves piecing together half-life data from scattered sources. This guide compiles the most well-documented half-life estimates into one clear, usable chart — covering growth hormone secretagogues, repair peptides, nootropic peptides, and more.
Understanding Peptide Half-Life: The Basics
Peptide half-life is shaped by several key factors, including amino acid sequence, molecular weight, route of administration, and whether the peptide has been modified for stability. Research-grade peptides that are unmodified tend to be degraded quickly by circulating enzymes called proteases.
Modified analogs — such as DAC (Drug Affinity Complex) versions or PEGylated peptides — are engineered to resist enzymatic breakdown, dramatically extending their active window. Understanding the difference between unmodified and modified peptides is essential when interpreting any half-life reference chart.
Complete Peptide Half-Life Reference Chart
The values below are drawn from published preclinical studies, pharmacokinetic research, and widely cited peptide science literature. These are research estimates — not dosing recommendations — and are intended purely for educational purposes.
Growth Hormone Secretagogues (GHS)
- Ipamorelin: Approximately 2 hours. A selective GHRP with a relatively short active window, studied for its clean GH-releasing profile with minimal cortisol or prolactin impact.
- CJC-1295 (no DAC): Approximately 30 minutes. The unmodified form of this GHRH analog is rapidly cleared, making it a common subject in pulsatile release research models.
- CJC-1295 with DAC: Approximately 6-8 days. The DAC modification allows albumin binding, dramatically extending its presence — a major variable studied in prolonged GH axis research.
- GHRP-6: Approximately 2-3 hours. One of the original GHRPs studied, research suggests it may influence ghrelin receptors and appetite-related pathways.
- GHRP-2: Approximately 1-2 hours. Studies indicate a potent GH-releasing effect with a shorter window compared to GHRP-6 in animal models.
- Sermorelin: Approximately 10-20 minutes. A truncated GHRH analog with a very short half-life, frequently referenced in pulsatile secretion studies.
- Tesamorelin: Approximately 25-38 minutes. A stabilized GHRH analog; pharmacokinetic studies have characterized its rapid clearance in human research models.
Repair and Recovery Peptides
- BPC-157: Approximately 4 hours (subcutaneous). This 15-amino-acid sequence derived from body protection compound has been extensively studied in rodent models for its effects on tissue and vascular pathways. [INTERNAL LINK: /products/bpc-157]
- TB-500 (Thymosin Beta-4 fragment): Approximately 1-3 days. The longer half-life of TB-500 compared to many peptides is attributed to its actin-binding properties and structural stability. [INTERNAL LINK: /products/tb-500]
- GHK-Cu (Copper Peptide): Approximately 1-2 hours in serum. Research into this naturally occurring tripeptide-copper complex has explored its role in collagen synthesis and tissue remodeling signals.
Nootropic and Neuropeptides
- Selank: Approximately 1-3 minutes (unmodified in plasma), though active metabolites may persist longer. Derived from the immunomodulatory peptide tuftsin, research models have examined its anxiolytic-like profile.
- Semax: Approximately 20 minutes to several hours depending on route. An ACTH analog studied for neuroprotective and cognitive pathway effects in animal research.
- DSIP (Delta Sleep-Inducing Peptide): Approximately 30-40 minutes. Despite its short plasma half-life, DSIP has been noted in research for lasting effects — a phenomenon researchers attribute to receptor-level activity that outlasts circulating peptide levels.
Longevity and Immune Peptides
- Epithalon: Approximately 30-60 minutes. A synthetic tetrapeptide studied in the context of telomere biology and pineal gland function in aging research models.
- Thymosin Alpha-1 (Ta1): Approximately 2 hours. Derived from the thymus gland, Ta1 has been the subject of immunomodulatory research across multiple preclinical and early-stage human studies.
- LL-37: Approximately 1-2 hours. A human cathelicidin-derived antimicrobial peptide studied for its role in innate immune signaling and barrier function.
Key Factors That Influence Peptide Half-Life
Half-life data points should always be interpreted with context. The following variables can significantly alter observed stability in research models:
- Route of administration: Subcutaneous delivery typically results in slower absorption and a longer effective window compared to intravenous injection.
- Peptide modifications: PEGylation, DAC attachment, or D-amino acid substitutions can multiply half-life from minutes to days.
- Temperature and storage: Improper storage accelerates peptide degradation before administration, skewing any real-world research observations.
- Species differences: Half-life values derived from rodent models do not translate directly to human pharmacokinetics — an important distinction for research interpretation.
How to Use This Chart in Your Research Protocol
Researchers often use half-life data to model dosing intervals in their study designs. For shorter half-life peptides like Sermorelin or CJC-1295 (no DAC), multiple daily administrations are commonly used in protocols studying pulsatile hormone patterns. For longer half-life options like CJC-1295 with DAC or TB-500, weekly or bi-weekly administration schedules appear more frequently in published research models.
Pairing peptides with complementary half-lives is another area of active research interest. Studies exploring Ipamorelin + CJC-1295 combinations, for example, leverage the synergy between a short-acting GHRP and a GHRH analog to model sustained GH axis activity — a topic covered in detail on the Maxx Labs research blog. [INTERNAL LINK: /blog/ipamorelin-cjc-1295-stack]
Storage Tips to Preserve Peptide Integrity
Half-life begins the moment a peptide is reconstituted. Research-grade peptides should be stored lyophilized (freeze-dried) at -20°C until use. Once reconstituted in bacteriostatic water, most peptides remain stable for 4-8 weeks when refrigerated at 2-8°C and protected from light exposure.
Always verify purity documentation — look for Certificates of Analysis (CoA) with HPLC data exceeding 98% purity — before incorporating any peptide into a research protocol. Maxx Labs provides third-party verified CoAs for every product in our catalog. [INTERNAL LINK: /lab-testing]
Disclaimer: All products offered by Maxx Laboratories are intended for in vitro and laboratory research purposes only. They are not intended for human or animal consumption, and are not meant to prevent, treat, or mitigate any disease or health condition. This content is for educational and informational use only. Always consult a qualified healthcare provider before making any decisions related to health or supplementation.